Key result
Higher waist-to-hip ratio, unlike BMI, linked to ~11% greater major cardiovascular events-3 risk per SD in T2D.
Why the study?
Anthropometric measures other than BMI are rarely assessed in clinical practice yet may be more predictive of cardiovascular risk in participants with type 2 diabetes.
Do central adiposity measures (waist-to-hip ratio, waist circumference) predict cardiovascular outcomes better than BMI in high-risk patients with type 2 diabetes?
Cohort (n=4,952)
Yes
Do central adiposity measures (waist-to-hip ratio, waist circumference) predict cardiovascular outcomes better than BMI in high-risk patients with type 2 diabetes?
Central adiposity measures (waist-to-hip ratio and waist circumference) are better predictors of MACE-3 and mortality than BMI in patients with type 2 diabetes, whereas BMI is a stronger predictor for heart failure hospitalization.
Answers are grounded in this paper and cite their sources.
May refine MACE risk stratification beyond BMI in high-risk T2D; hypothesis-generating and requires prospective validation.
BACKGROUND: In clinical practice, anthropometric measures other than BMI are rarely assessed yet may be more predictive of cardiovascular (CV) risk. We analyzed the placebo group of the REWIND CV Outcomes Trial to compare several anthropometric measures as baseline risk factors for cardiovascular disease (CVD)-related outcomes in participants with type 2 diabetes (T2D). METHODS: . Cox proportional hazard models were used to investigate if BMI, waist-to-hip ratio (WHR), and waist circumference (WC) were significant risk factors for major adverse CV events (MACE)-3, CVD-related mortality, all-cause mortality, and heart failure (HF) requiring hospitalization. Models were adjusted for age, sex, and additional baseline factors selected by LASSO method. Results are presented for one standard deviation increase of the respective anthropometric factor. RESULTS: Participants in the placebo group experienced 663 MACE-3 events, 346 CVD-related deaths, 592 all-cause deaths, and 226 events of HF requiring hospitalization during the median follow-up of 5.4 years. WHR and WC, but not BMI, were identified as independent risk factors of MACE-3 (hazard ratio [HR] for WHR: 1.11 [95% CI 1.03 to 1.21]; p = 0.009; HR for WC: 1.12 [95% CI 1.02 to 1.22]; p = 0.012). WC adjusted for hip circumference (HC) showed the strongest association with MACE-3 compared to WHR, WC, or BMI unadjusted for each other (HR: 1.26 [95% CI 1.09 to 1.46]; p = 0.002). Results for CVD-related mortality and all-cause mortality were similar. WC and BMI were risk factors for HF requiring hospitalization, but not WHR or WC adjusted for HC (HR for WC: 1.34 [95% CI 1.16 to 1.54]; p < 0.001; HR for BMI: 1.33 [95% CI 1.17 to 1.50]; p < 0.001). No significant interaction with sex was observed. CONCLUSIONS: In this post hoc analysis of the REWIND placebo group, WHR, WC and/or WC adjusted for HC were risk factors for MACE-3, CVD-related mortality, and all-cause mortality; while BMI was only a risk factor for HF requiring hospitalization. These findings indicate the need for anthropometric measures that consider body fat distribution when assessing CV risk.
No takes yet. Share an insight, caveat, or question.
Franek et al. (2023) conducted a cohort in Type 2 diabetes with high cardiovascular risk (n=4,952). Waist-to-hip ratio (per 1 SD increase) vs. Lower waist-to-hip ratio was evaluated on MACE-3 (HR 1.11, 95% CI 1.03-1.21, p=0.009). In patients with type 2 diabetes and high cardiovascular risk, a one standard deviation increase in waist-to-hip ratio was associated with an increased risk of major cardiovascular events-3, whereas BMI was not.
Synapse has enriched 10 related papers. Consider them for comparative context: